ONOPCHENKO JOHN (CEO and Director) sold 34.9% of their position (88.98K shares) of ENDOLOGIX INC /DE/ on the open market
Open‑market sale worth $53.4K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 8/14/2020ACC: 0001013606-20-000170
DirectorOfficer· CEO and Director
Since Dec 2018
-88.98K
Net shares
Net seller
$53.4K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
88.98K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−57.41K
Price / share
$0.88
Trade value
$50.73K
% of position
22.5%
8/12/2020
254.68K→197.26K
Common Stock
Direct
Shares
−1.31K
Price / share
$0.09
Trade value
$114.93
% of position
0.7%
8/12/2020
197.26K→195.96K
Common Stock
Direct
Shares
−30.26K
Price / share
$0.08
Trade value
$2.51K
% of position
15.4%
8/12/2020
195.96K→165.70K
Total
Net shares
−88.98K
Net value
-$53.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/12/2020 | S · Sale | −57.41K | $0.88 | $50.73K | 22.5% | 254.68K | 197.26K |
| Common Stock Direct | 8/12/2020 | S · Sale | −1.31K | $0.09 | $114.93 | 0.7% | 197.26K | 195.96K |
| Common Stock Direct | 8/12/2020 | S · Sale | −30.26K | $0.08 | $2.51K | 15.4% | 195.96K | 165.70K |
| Total | −88.98K | -$53.36K | ||||||
Derivative Transactions0
No derivative transactions reported